ConMed Maintains Cautious Outlook on Pandemic Recovery

ConMed reported 3Q21 orthopedic revenue of $105.8 million, +3.5% vs. 3Q19. The company saw the negative impact of COVID-19's Delta variant grow throughout the third quarter and peak in late September. Like its peers, ConMed experienced worse procedure declines in the U.S. compared to international markets, though the company's international...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us